ARTICLE | Clinical News
Replagal agalsidase alfa regulatory update
January 14, 2002 8:00 AM UTC
Israel, Switzerland and the Czech Republic granted marketing approval for TKTX's Replagal to treat Fabry disease. The product is approved in Europe and is under FDA review. ...